[1]. Delogu, G., M. Sali, and G. Fadda, The biology of mycobacterium tuberculosis infection. Mediterranean journal of hematology and infectious diseases, 2013; 5(1): e2013070 .
[2]. Shahraki, A.H., et al., "Multidrug-resistant tuberculosis" may be nontuberculous mycobacteria. Eur J Intern Med, 2015; 26(4): 279-84 .
[3]. Gholami, K., et al., Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients. Pharm Pract (Granada), 2006; 4(3): 134-8 .
[4]. Babamahmoodi, F., et al., Clinical Epidemiology and Paraclinical Findings in Tuberculosis Patients in North of Iran. BioMed Research International, 2015; 2015: 5 .
[5]. Karbalaei Zadeh Babaki, M., S. Soleimanpour, and S.A. Rezaee, Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design. Microb Pathog, 2017; 112: 20-29.
[6]. Nour-Neamatollahie, A., et al., Distribution of nontuberculosis mycobacteria strains from suspected tuberculosis patients by heat shock protein 65 PCR-RFLP. Saudi journal of biological sciences, 2017. 24(6):1380-1386.
[7]. Forbes, B.A., et al., Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria. Clinical Microbiology Reviews, 2018. 31(2):e00038-17.
[8]. O'Donnell, M.R., et al., Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow CytometryBased Phenotyping and Whole-Genome Sequencing. Antimicrob Agents Chemother, 2019. 63(4):01834-18.
[9]. De Lorenzo, S. and S. Tiberi, Tuberculosis a re-emerging disease. Intern Emerg Med, 2012. 7(3):012-0822.
[10]. Pourostadi, M., et al., Tuberculosis Control and Role of Molecular Epidemiology Studies in Iran: A Systematic Review. Tanaffos, 2017. 16(3):190-200.
[11]. Jahangard E, S.t.S., Income Distribution Modeling on tuberculosis in Iran: Comparison of Dagum Model and Other Models Selected. quartery journal of economical modeling, 2014. 8(26):21-36.
[12]. Hajarizadeh, B., A. Mirjalili, and M. Mohraz, Epidemiology of Mycobacterium tuberculosis infection among Iranian HIV– infected patients. American Journal of Infection Control, 2005. 33(5):e98.
[13]. Sahebi, L., et al., Molecular Epidemiology of Mycobacterium Tuberculosis Strains in the North-West and West of Iran. Annals of medical and health sciences research, 2015. 5(5):334339.
[14]. Aminifar M, S.A., Ahmadan E., Approach to tuberculosis in air travelers. Ebnesina, 2011. 14(1-2 ):(39-40).
[15]. Arsang-Jang, S., et al., Epidemiologic Trend of Smear-Positive, Smear-Negative, Extra Pulmonary and Relapse of Tuberculosis in Iran (2001-2015); A Repeated Cross-Sectional Study. J Res Health Sci, 2017. 17(2).
[16]. Arsang SH , Kazemnejad A , and Amani F Epidemiology of Tuberculosis in Iran (2001-08). Journal of Gorgan University of Medical Sciences, 2011. 13(3):78-86.
[17]. Rashedi, J., et al., Multidrug-resistant tuberculosis in northwest of Iran and Republic of Azerbaijan: a major public health concern for Iranian people. J Res Health Sci, 2015. 15(2):101-3.
[18]. Steingart, K.R., et al., Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis, 2006. 6(9):570-81.
[19]. Beiranvand, R., et al., Epidemiology of Tuberculosis in southwest of Iran: a brief report. Tehran University Medical Journal, 2014. 72(4):263-267.
[20]. Metanat M, S.M., Sharifi Mood B, Jahan Tigh and R.Z. AR, Epidemiology of extra-pulmonary Tuberculosis in Zahedan [Persian]. . zahedan journal of research in medical sciences, 2006. 13(9):34-37. [21]. Gholami, A., et al., Epidemiologic survey of pulmonary tuberculosis in Urmia city during 2004-2007. Knowledge and Health, 2009. 4(3):45-48.
[22]. Tarverdizadeh Y, I.F.A.A., Investigation of perdisposing and enviromental factors in tuberculosis (TB). Journal of Medical Council of I.R.I., 2013. 30(4):23-27.
)